CinRx raises $73M to create more biotechs, further support obesity drug development

Cin­Rx Phar­ma, the cre­ator of biotechs like Cin­Cor, which was ac­quired by As­traZeneca, raised an­oth­er $73 mil­lion to sup­port its cur­rent port­fo­lio …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.